Scroll Top
Gain Therapeutics Inc.

Jonas Hannestad, MD, PhD: Phase 1b Interim Data on GT-02287 in Parkinson Disease

NeurologyLive

Oct 05, 2025

Jonas Hannestad, MD, PhD: Phase 1b Interim Data on GT-02287 in Parkinson Disease

 

Latest Articles

Clear Filters
October 9, 2025
Allosteric small molecule therapies in PD, with Gene Mack
https://pharmaphorum.com/rd/allosteric-small-molecule-therapies-pd-gene-mack
Read More
October 8, 2025
Early data suggest GT-02287 slows Parkinson’s disease
https://www.ddw-online.com/early-data-suggest-gt-02287-slows-parkinsons-disease-37433-202510/
Read More
October 8, 2025
New Parkinson’s Drug GT-02287 Shows Promising Phase 1b Data
https://www.clinicaltrialvanguard.com/news/new-parkinsons-drug-gt-02287-shows-promising-phase-1b-data/
Read More